Georgia Cancer Center at Augusta University — Augusta, Georgia

Georgia Cancer Center at Augusta University is a clinical research site located in Augusta, Georgia, United States 30912.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Georgia Cancer Center at Augusta University has participated in 52 clinical trials with 24 currently active.

Therapeutic areas: Leukemia, Myeloid, Acute, AML, AML With Mutated NPM1.

Sponsors: Delta-Fly Pharma, Inc., Kura Oncology, Inc., Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgia Cancer Center at Augusta University?

Georgia Cancer Center at Augusta University has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgia Cancer Center at Augusta University conducted?

Georgia Cancer Center at Augusta University has 52 clinical trials on record, with 24 currently active. Their work covers Leukemia, Myeloid, Acute, AML, AML With Mutated NPM1.

Is Georgia Cancer Center at Augusta University accredited by Crixeo Health?

Yes — Georgia Cancer Center at Augusta University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Georgia Cancer Center at Augusta University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.